Abstract
Evidence from peer-reviewed literature is the cornerstone for designing responses to global threats such as COVID-19. The collection of knowledge and interpretation in publications needs to be distilled into evidence by leveraging natural language in ways beyond standard meta-analysis. Several studies have focused on mining evidence from text using natural language processing, and have focused on a handful of diseases. Here we show that new knowledge can be captured, tracked and predicted using the evolution of unsupervised word embeddings and machine learning. Our approach to decipher the flow of latent knowledge in time-varying networks of word-vectors captured thromboembolic complications as an emerging theme in more than 77,000 peer-reviewed publications and more than 11,000 WHO vetted preprints on COVID-19. Furthermore, machine learning based prediction of emerging links in the networks reveals autoimmune diseases, multisystem inflammatory syndrome and neurological complications as a dominant research theme in COVID-19 publications starting March 2021.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was partially supported by the Wellcome Trust/DBT India Alliance Fellowship IA/CPHE/14/1/501504 awarded to Tavpritesh Sethi. We also acknowledge support from the Center of Excellence in Healthcare and the Center of Excellence in Artificial Intelligence at IIIT-Delhi.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study involved analysis of a publicly available database on COVID-19 literature maintained by the WHO at https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
The paper presents the detection and prediction of emerging themes in the networks of diseases extracted from the COVID-19 scientific literature over the months. In this revised version, previous results have been updated for the subsequent months of 2021. The temporal link prediction model has been improved using ARIMA for time series forecasting of the node-to-node proximity scores and using them as features in supervised machine learning models for binary classification of links. These updates enhanced the proposed architecture and incorporated more analyses with the interpretable clusters of diseases added in the results section.
Data Availability
All the data used in this study are publicly available from the WHO Covid-19 Global Literature on coronavirus disease maintained at https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov. Our analysis and the interactive resource EvidenceFlow is publicly available in a user-friendly fashion at https://evidenceflow.tavlab.iiitd.edu.in/
